Tyr-W-MIF-1

CAT:
804-HY-P3087
Size:
Inquire
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tyr-W-MIF-1 - image 1

Tyr-W-MIF-1

  • CAS Number:

    144450-13-5
  • UNSPSC Description:

    Tyr-W-MIF-1 is an opioid tetrapeptide with opiate and antiopiate activity. Tyr-W-MIF-1 can induce analgesia[1][2][5].
  • Target Antigen:

    Opioid Receptor
  • Type:

    Peptides
  • Related Pathways:

    GPCR/G Protein;Neuronal Signaling
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Neurological Disease
  • Assay Protocol:

    https://www.medchemexpress.com/tyr-w-mif-1.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C(NCC(N)=O)[C@@H](NC([C@H](CCC1)N1C([C@@H](N)CC(C=C2)=CC=C2O)=O)=O)CC3=CNC4=CC=CC=C34
  • Molecular Weight:

    520.58
  • References & Citations:

    [1]Yang YR, et L. Opioid and antiopioid actions of Tyr-MIF-1, Tyr-W-MIF-1 and hemorphin-4 on rat locus coeruleus neurons: intracellular recording in vitro. Chin J Physiol. 1997 Sep 30;40(3):131-5. |[2]Gergen KA, et al. Expression of the FOS proto-oncogene protein in brain after ICV administration of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2). Peptides. 1994;15(8):1505-11. |[3]Gergen KA, et al. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors. Eur J Pharmacol. 1996 Mar 18;298(3):235-9. |[4]Harrison LM, et al. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells. J Pharmacol Exp Ther. 1998 Feb;284(2):611-7. |[5]Erchegyi J, et al. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1). Peptides. 1992 Jul-Aug;13(4):623-31.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported